EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

about

Visfatin Promotes IL-6 and TNF-α Production in Human Synovial Fibroblasts by Repressing miR-199a-5p through ERK, p38 and JNK Signaling Pathways.HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer.

P2860

Q48278219-09ABFD9A-56C9-4AB6-AEDD-E2016B63573C Q55264202-8C9A239E-E0BF-4BFD-8900-8753F9816D8E

P2860

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

Item

http://www.wikidata.org/entity/Q47107525

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@en

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@nl

type

Item

label

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@en

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@nl

prefLabel

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@en

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@nl

P1476

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

@en

P2093

Bi-Fei Huang

http://www.w3.org/2001/XMLSchema#string

Chao-Qun Wang

http://www.w3.org/2001/XMLSchema#string

Chen-Ming Su

http://www.w3.org/2001/XMLSchema#string

Chih-Hsin Tang

http://www.w3.org/2001/XMLSchema#string

Dongfang Guo

http://www.w3.org/2001/XMLSchema#string

Gui-Nv Hu

http://www.w3.org/2001/XMLSchema#string

Hui Yuan

http://www.w3.org/2001/XMLSchema#string

Qian Wang

http://www.w3.org/2001/XMLSchema#string

Tengyun Long

http://www.w3.org/2001/XMLSchema#string

Xiaoni Li

http://www.w3.org/2001/XMLSchema#string

P2860

CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3

Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro

Cell signaling by receptor tyrosine kinases

Untangling the ErbB signalling network

Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain Barrier

The ErbB signaling network: receptor heterodimerization in development and cancer

The epidermal growth factor receptor and its inhibition in cancer therapy.

Epidermal growth factor receptor: mechanisms of activation and signalling.

P2888

s41598-017-15939-9

P304

15654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-15939-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29142206

http://www.w3.org/2001/XMLSchema#string

P932

5688137

http://www.w3.org/2001/XMLSchema#string

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

about

P2860

P2860

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932